Allogeneic mitochondrial transplantation ameliorates cardiac dysfunction due to doxorubicin: An in vivo study
Open Access
- 9 October 2023
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 168, 115651
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Medical Research Development (988191)
This publication has 36 references indexed in Scilit:
- Molecular mechanism of doxorubicin-induced cardiomyopathy – An updateEuropean Journal of Pharmacology, 2018
- Transit and integration of extracellular mitochondria in human heart cellsScientific Reports, 2017
- Mitochondrial transplantation: From animal models to clinical use in humansMitochondrion, 2017
- Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantroneArchives of Toxicology, 2016
- Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targetsArchives of Toxicology, 2015
- Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell deathBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- NADPH oxidases participate to doxorubicin-induced cardiac myocyte apoptosisBiochemical and Biophysical Research Communications, 2009
- Doxorubicin Induces Apoptosis by Activation of Caspase-3 in Cultured Cardiomyocytes In Vitro and Rat Cardiac Ventricles In VivoJournal of Pharmacological Sciences, 2006
- Nuclear magnetic resonance study of doxorubicin binding to cardiolipin containing magnetically oriented phospholipid bilayersBiochimica et Biophysica Acta (BBA) - Biomembranes, 2001
- A fluorometric method for determination of oxidized and reduced glutathione in tissuesAnalytical Biochemistry, 1976